doxazosin has been researched along with ramipril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Acikel, C; Caglar, K; Celik, T; Eyileten, T; Oguz, Y; Sonmez, A; Vural, A; Yavuz, I; Yenicesu, M; Yilmaz, MI | 1 |
| Jekell, A; Kahan, T; Kalani, M | 2 |
| Jekell, A; Kahan, T | 1 |
| Ekholm, M; Gigante, B; Jekell, A; Kahan, T; Wallén, NH | 1 |
| De Angelis, MV; Di Stefano, V; Onofrj, M; Rispoli, MG | 1 |
1 review(s) available for doxazosin and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for doxazosin and ramipril
| Article | Year |
|---|---|
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Topics: Adiponectin; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Doxazosin; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Metoprolol; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2007 |
The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Linear Models; Male; Middle Aged; Pulse Wave Analysis; Ramipril; Renin-Angiotensin System; Sweden; Treatment Outcome; Vascular Stiffness | 2017 |
Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Double-Blind Method; Doxazosin; Female; Hemostasis; Humans; Hypertension; Inflammation; Inflammation Mediators; Male; Middle Aged; Ramipril; Renin-Angiotensin System; Sweden; Time Factors; Treatment Outcome | 2018 |
4 other study(ies) available for doxazosin and ramipril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study.
Topics: Antihypertensive Agents; Arterial Pressure; Doxazosin; Female; Humans; Male; Middle Aged; Ramipril; Vascular Stiffness | 2018 |
The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Doxazosin; Echocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Prognosis; Pulse Wave Analysis; Ramipril; Skin; Vasodilation | 2019 |
Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.
Topics: Antihypertensive Agents; Brain Stem; Calcium Channel Blockers; Diagnosis, Differential; Doxazosin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Posterior Leukoencephalopathy Syndrome; Ramipril; White Matter | 2020 |